Heart disease continues to claim millions of lives annually, with obesity and excess weight dramatically increasing risk. While lifestyle modifications remain foundational for cardiovascular health, ...

* Glucagon-like peptide-1 receptor agonists reduce major cardiovascular events in type 2 diabetes * Real-world outcomes closely match results from large-scale clinical //trials * Both semaglutide and ...

University of Connecticut investigators found that resveratrol can be an effective substitute for aspirin in preventing heart attacks. A branded resveratrol pill, Longevinex, was found to afford the ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, semaglutide (Ozempic) and tirzepatide (Mounjaro), not only promote weight loss ...